| abstract |
Provided are: a clinically usable medicine to be used for fundamentally treating Alzheimer's disease (AD); and a therapeutic agent for neurological diseases, other than AD, associated with nerve axon dysfunction with the application of the function mechanism for fundamentally treating AD. The aforesaid medicine or therapeutic agent is an orally administrable agent characterized by comprising one or more compounds selected from among diosgenin, a diosgenin derivative and pharmaceutically acceptable salts thereof, said compound(s) being suspended in an edible oil. |